Ledipasvir plus sofosbuvir: hint of added benefit in certain patients

The drug combination of ledipasvir and sofosbuvir (trade name Harvoni) has been available since November 2014 for the treatment of ...

Read more →

Just look, but don’t touch: EMA terms of use for clinical study data are impracticable

The European Medicines Agency (EMA) receives comprehensive clinical study data from drug manufacturers. These data form the basis for the ...

Read more →

Aflibercept in macular oedema after branch retinal vein occlusion: no hint of added benefit

15 Juen 2015 - Since February 2015, aflibercept (trade name Eylea) has been available also for patients with impaired vision ...

Read more →

Dulaglutide in type 2 diabetes: hint of an added benefit in combination with short-acting insulin

Since 2014 dulaglutide has been approved alone or in combination with other drugs for the treatment of adults with type ...

Read more →

Lurasidone in schizophrenia: added benefit is not proven

The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The ...

Read more →

IQWiG commences 4 new assessments

IQWiG has announced that it has commenced its assessment of the following medicines: ...

Read more →

Propranolol in proliferating infantile haemangioma: indication of major added benefit in certain patients

The Institute for Quality and Efficiency in Health Care (IQWiG) investigated in a dossier assessment whether propranolol offers an added ...

Read more →

Germany's IQWiG has found that pertuzumab (Perjeta) has significant added value in certain patients with advanced breast cancer

[:content [\P \e \r \t \u \z \u \m \a \b \space \( \P \e \r \j \e \t \a \) \  \w \a \s \space \l \a \u \n \c \h \e \d \space \i \n \space \G \e \r \m \a \n \y \space \i \n \  \M \a \r \c \h \space \2 \0 \1 \3 \space \f \o \r \space \u \s \e \  \a \s \space \a \d \j \u \n \c \t \i \v \e \space \t \h \e \r \a \p \y \space \b \y \space \c \e \r \t \a \i \n \space \p \a \t \i \e \n \t \s \space \w \i \t \h \space \a \d \v \a \n \c \e \d \  \H \E \R \2 \- \p \o \s \i \t \i \v \e \space \b \r \e \a \s \t \space \c \a \n \c \e \r \. \  " ..."]]
Read more →

Teriflunomide in multiple sclerosis: added benefit not proven

[:content [\T \e \r \i \f \l \u \n \o \m \i \d \e \space \( \A \u \b \a \g \i \o \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \i \n \space \G \e \r \m \a \n \y \space \s \i \n \c \e \space \A \u \g \u \s \t \space \2 \0 \1 \3 \space \f \o \r \space \a \d \u \l \t \s \space \w \i \t \h \space \r \e \l \a \p \s \i \n \g \space \r \e \m \i \t \t \i \n \g \space \m \u \l \t \i \p \l \e \space \s \c \l \e \r \o \s \i \s \. \space \I \n \space \a \n \space \e \a \r \l \y " ..."]]
Read more →

Novo Nordisk changes strategy in Germany, launches diabetes drug

Danish drugmaker Novo Nordisk, the world's biggest insulin producer, said on Wednesday it had decided to launch its diabetes drug ...

Read more →

Dolutegravir/abacavir/lamivudine: considerable added benefit for treatment-naive adults with HIV

Since September 2014, the fixed-dose combination of dolutegravir/abacavir/lamivudine (trade name Triumeq) has been approved for human immunodeficiency virus (HIV) infected ...

Read more →

Early benefit assessment increases transparency for study data

Four years have passed since the introduction of the German Act on the Reform of the Market for Medicinal Products ...

Read more →

EU clears German scheme to exempt pharma groups from price freezes

The European Commission on Friday cleared a German scheme that allowed exceptions to be made for pharmaceutical groups whose medicines ...

Read more →

Additional benefits of canagliflozin are not occupied

Canagliflozin (Invokana) has been approved since November 2013 for use as monotherapy and in various combination therapies for adults with type 2 iabetes mellitus, ...

Read more →

Sipuleucel-T in prostate cancer: added benefit is not proven

Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or ...

Read more →